Resources Contact Us Home
Solid oral dosage form containing an enhancer

Image Number 17 for United States Patent #8119159.

The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to promote absorption of the bisphosphonate at the GIT cell lining. The enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.

  Recently Added Patents
Support member, rotation device comprising such a support and rolling bearing assembly including such a detection device
Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
Floor standing rack
Integrated advance copper fuse combined with ESD/over-voltage/reverse polarity protection
Coordinated garbage collection for raid array of solid state disks
Sublingual coated tablet of fentanyl
Implicit certificate scheme
  Randomly Featured Patents
Anionic and neutral complexes of ruthenium (II) with nitrogen oxide
Handheld computing device
Protective circuit for electronic modules, especially driver modules
Transport method and transport apparatus
Preparation of aluminum hydride polymorphs, particularly stabilized .alpha.-alh3
Beamformer and beamforming method
Bearing life extender for conveyor type rollers
Biologically active benzothiazolone ethanamines
Halogen compound promoted Al.sub.2 O.sub.3 and/or SiO.sub.2 for the preparation of isoalkenes
Lock lever mounting bracket for headrails on coverings for architectural openings